KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Change in Account Payables (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Change in Account Payables data on record, last reported at -$37.9 million in Q4 2025.

  • For Q4 2025, Change in Account Payables fell 427.84% year-over-year to -$37.9 million; the TTM value through Dec 2025 reached $2.9 million, up 120.1%, while the annual FY2025 figure was $2.9 million, 120.1% up from the prior year.
  • Change in Account Payables reached -$37.9 million in Q4 2025 per CRL's latest filing, down from $24.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $40.9 million in Q1 2022 and bottomed at -$41.3 million in Q2 2023.
  • Average Change in Account Payables over 5 years is $521000.0, with a median of -$1.1 million recorded in 2023.
  • The widest YoY moves for Change in Account Payables: up 3818.66% in 2025, down 528.03% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $33.5 million in 2021, then tumbled by 125.79% to -$8.6 million in 2022, then surged by 170.72% to $6.1 million in 2023, then crashed by 217.56% to -$7.2 million in 2024, then crashed by 427.84% to -$37.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$37.9 million in Q4 2025, $24.5 million in Q3 2025, and -$9.0 million in Q2 2025.